Active ingredientLofexidineCat. No. P-L083-001CAS 31036-80-3Family · Pharmaceutical analytical standards
Lofexidine
An alpha-2A adrenergic receptor agonist that reduces noradrenaline release and eases the symptoms of opioid withdrawal; in the United Kingdom it has been used for this purpose since 1992. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Originally a medicine for high blood pressure, in 2018 it became the first non-opioid drug approved in the United States for the treatment of opioid withdrawal.
Go to the active ingredient →Active ingredientLofexidineCat. No. P-L083-001CAS 31036-80-3
Active ingredientLofexidine HydrochlorideCat. No. P-L083-002CAS 21498-08-8
Isotopically labelledLofexidine-d4Cat. No. P-L083-003CAS 78302-26-8
Isotopically labelledLofexidine-d4 HydrochlorideCat. No. P-L083-004CAS 1206845-57-9
Impurity(R)-LofexidineCat. No. P-L083-005CAS 81447-78-1
Impurity(S)-LofexidineCat. No. P-L083-006CAS 81447-79-2No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.